Stronger Warnings on Avandia and Certain Diabetes Drugs
The manufacturers of thiazolidinedione drugs have strengthened warnings about the risks of basics failure with these medications, which are use to treat type 2 diabetes. They are sold as Avandia (rosiglitazone maleate), Avandaryl (rosiglitazone maleate and glimepiride), and Avandamet (rosiglitazone maleate and metformin hydrochloride), which all admit rosiglitazone, and Actos (pioglitazone hydrochloride), Duetact (pioglitazone hydrochloride and glimepride) and Actoplus met, which all contain pioglitazone. The sedative labels already had information about heart failure risk, but now there is a new boxed warning that re-emphasizes that these drugs may bring on or worsen heart failure in...